- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Clinical Trial
Recent news which mentions Clinical Trial
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
September 20, 2024
From Benzinga
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
September 05, 2024
From Benzinga
Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients
August 20, 2024
From Benzinga
IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
June 25, 2024
From PRLog
Federal Money To Support Research On Psychedelics As Alternative To Pills For Chronic Pain Among The Elderly
April 29, 2024
Tickers
NEWS
From Benzinga
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
March 08, 2024
From Benzinga
Game Changing Move? NFL Tackles Pain And Concussions In CBD Clinical Trial Partnership With Canadian University
January 17, 2024
From Benzinga
Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation
December 21, 2023
Tickers
AWKNF
From Benzinga
Expert Opinions on Dry Eye Treatment Innovations
July 13, 2023
From PRLog
Cybin: Positive Clinical Trial On Psilocybin Analog For Major Depression & Updates On DMT Analog Program
March 02, 2023
Tickers
CYBN
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
From Benzinga
From Benzinga
Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology
October 18, 2022
Tickers
ATAI
From Benzinga
Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment
October 07, 2022
From Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
September 08, 2022
Tickers
AGNPF
From Benzinga
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
June 15, 2022
From PRLog
From Benzinga
Charlotte's Web: Positive Results In Clinical Trial Of Hemp-Derived CBD For Stress, Sleep And Well-Being
February 08, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.